Chronic hepatitis caused by hepatitis E virus and treated with ribavirin

被引:1
|
作者
Mora Soler, Ana Maria [1 ]
Velasco-Guardado, Antonio [1 ]
Martin Arribas, Maria Isabel [1 ]
Acosta Materan, Rosa [1 ]
Revilla Morato, Cristina [1 ]
Perez Corte, Daniel [1 ]
Rodriguez Perez, Antonio [1 ]
机构
[1] Hosp Univ Salamanca, Serv Aparato Digest, Inst Invest Biomed Salamanca, Salamanca, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2016年 / 39卷 / 09期
关键词
INFECTION;
D O I
10.1016/j.gastrohep.2015.09.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:597 / 598
页数:2
相关论文
共 50 条
  • [21] SAFETY OF THE COMBINED TREATMENT OF CHRONIC HEPATITIS VIRUS C WITH RIBAVIRIN AND PEGINTERFERON ALPHA
    Neus, Sunyer Esquerra
    Isabel, De la Paz Castizares
    Sanchez Blanca, Martinez
    Maria Teresa, Butina Agusti
    ATENCION FARMACEUTICA, 2012, 14 (06): : 453 - 456
  • [22] Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin
    Fouad, Yasser M.
    Khalaf, Hanaa
    Ibraheem, Hala
    Rady, Heba
    Helmy, Amal K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (01) : E67 - E71
  • [23] Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
    Caviglia, Gian Paolo
    Abate, Maria Lorena
    Manzini, Paola
    Danielle, Franca
    Ciancio, Alessia
    Rosso, Chiara
    Olivero, Antonella
    Pellicano, Rinaldo
    Touscoz, Giovanni Antonio
    Smedile, Antonina
    Rizzetto, Mario
    HEPATITIS MONTHLY, 2012, 12 (11) : e7292
  • [24] Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity
    Debing, Yannick
    Ramiere, Christophe
    Dallmeier, Kai
    Piorkowski, Geraldine
    Trabaud, Mary-Anne
    Lebosse, Fanny
    Scholtes, Caroline
    Roche, Magali
    Legras-Lachuer, Catherine
    de Lamballerie, Xavier
    Andre, Patrice
    Neyts, Johan
    JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 499 - 508
  • [25] Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
    Lhomme, Sebastien
    DebRoy, Swati
    Kamar, Nassim
    Abravanel, Florence
    Metsu, David
    Marion, Olivier
    Dimeglio, Chloe
    Cotler, Scott J.
    Izopet, Jacques
    Dahari, Harel
    VIRUSES-BASEL, 2019, 11 (07):
  • [26] Persistence of hepatitis E virus in the cerebrospinal fluid despite apparently successful ribavirin therapy
    Lhomme, Sebastien
    Fayard, Amandine
    Mirafzal, Sonia
    Carcenac, Romain
    Boyer, Pauline
    Latour, Justine
    Brebion, Amelie
    Bay, Jacques-Olivier
    Henquell, Cecile
    Izopet, Jacques
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2300 - 2303
  • [27] Seroprevalence of hepatitis E virus in patients with chronic liver disease
    de Araujo, Lilian Rose Maia Gomes
    Batista, Andrea Doria
    Coelho, Maria Rosangela Cunha Duarte
    Santos, Joelma Carvalho
    Cunha, Gabriel Galindo
    Leal, Gabriela Rodrigues Aguiar
    Pinho, Joao Renato Rebello
    Domingues, Ana Lucia Coutinho
    Lopes, Edmundo Pessoa
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2024, 55 (01) : 357 - 364
  • [28] Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin
    Del Bello, A.
    Guilbeau-Frugier, C.
    Josse, A. -G.
    Rostaing, L.
    Izopet, J.
    Kamar, N.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) : 279 - 283
  • [29] Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands
    Tholen, Aletta T. R.
    Schinkel, Janke
    Molenkamp, Richard
    Ang, C. Wim
    PLOS ONE, 2016, 11 (02):
  • [30] Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease
    Atiq, Muslim
    Shire, Norah J.
    Barrett, Anna
    Rouster, Susan D.
    Sherman, Kenneth E.
    Shata, Mohamed T.
    EMERGING INFECTIOUS DISEASES, 2009, 15 (03) : 479 - 481